A quick peek into the report
Table of Contents
Product Definition
2.1 Scope of Study
2.2 Inclusion and Exclusion Criteria of the Report
2.3 Key Questions Answered by Research Study
3.1 Primary Data Sources
3.2 Secondary Data Sources
3.3 Data Sources Categorization
3.4 Selection Criteria for Company Profiles
3.5 Brief Overview of the Market Estimation Process
3.6 Data Validation
3.7 Assumptions and Limitations
4.1 Epidemiology of Mental Health Disorders
4.2 Regional Prevalence of Mental Health Disorders
4.2.1 North America
4.2.2 Europe
4.2.3 Asia-Pacific
4.2.4 Rest-of-the-World
4.3 Psychiatrist Density
4.3.1 North America
4.3.2 Europe
4.3.3 Asia-Pacific
4.4 Reimbursement Landscape
4.4.1 U.S.
5.1 Impact of COVID-19 on Regulatory Framework
5.2 Impact on Global Emerging Mental Health Devices and Platforms Market Size
5.2.1 Scenario Comparison Analysis
5.2.2 Key Developments During COVID-19 Pandemic
5.3 Impact of COVID-19 on Adoption of Emerging Mental Health Devices and Platforms
5.3.1 Short-Term Impact
5.3.2 Mid-Term Impact
5.3.3 Long-Term Impact
5.4 Entry Barriers and Opportunities for Companies Entering the Market
6.1 Technology Landscape
6.1.1 Key Trends
6.1.1.1 Short-Term Potential (2-4 Years)
6.1.1.2 Mid-Term Potential (5-10 Years)
6.1.1.3 Long-Term Potential (8-12 Years)
6.2 Value Chain Analysis
6.3 Medical Cost Savings Analysis
6.4 Funding Scenario
6.5 Associations and Consortiums
6.6 Regulatory Framework
6.6.1 Regulations in North America
6.6.1.1 U.S.
6.6.1.2 Canada
6.6.2 Regulations in Europe
6.6.3 Regulations in Asia-Pacific
6.6.3.1 Japan
6.6.3.2 China
6.6.4 Regulations in Rest-of-the-World
6.7 Patent Analysis
7.1 Market Share Analysis
7.1.1 Global Emerging Mental Health Devices and Platforms Market Share Analysis (by Company)
7.1.2 Global Emerging Mental Health Platforms Market (by Company)
7.2 Key Strategies and Developments
7.2.1 Partnerships, Collaborations, and Business Expansion
7.2.2 Funding Activities
7.2.3 New Offerings
7.2.4 Regulatory and Legal
7.2.5 Mergers and Acquisitions Activities
7.3 Growth Share Matrix
7.3.1 Growth Share Matrix (by Product Type)
7.3.2 Growth Share Matrix (by Application)
7.4 Product Mapping Analysis
7.5 Business Model Analysis
7.6 Pricing Analysis
7.7 Pipeline Analysis
8.1 Assumptions and Limitations
8.2 Key Findings and Opportunity Assessment
8.2.1 Key Findings
8.2.2 Opportunity Assessment
8.3 Global Emerging Mental Health Devices and Platforms Market Size and Forecast
8.3.1 Realistic Growth Scenario
8.3.2 Pessimistic/Conservative Growth Scenario
8.3.3 Optimistic Growth Scenario
8.4 Market Dynamics
8.4.1 Market Drivers
8.4.1.1 Growing Demand for Teleconsultations in the Wake of COVID-19 Pandemic
8.4.1.2 Increasing Funding Activity in Digital Mental Health Landscape
8.4.1.3 Rising Adoption of Digital Mental Health Solutions in Emerging Economies
8.4.1.4 Entry of Pharmaceutical Companies in Digital Mental Health Paradigm
8.4.2 Market Restraints
8.4.2.1 Lack of Clinically Validated Scientific Data
8.4.2.2 User Data Privacy Concerns
8.4.3 Impact Analysis
8.4.4 Market Opportunities
8.4.4.1 Development of Portable Mental Health Devices
8.4.4.2 Development of Novel Therapies for Mental Health Treatment
8.4.4.3 Product Portfolio Expansion
8.4.4.3.1 Technology Integrated Solutions for Severe Mental Health Illnesses
8.4.4.3.2 Provider-Centric Mental Health Platforms
8.4.4.4 Business Collaborations
8.4.4.4.1 Partnership Between Non-Healthcare Companies and Mental Health Platform Developers
8.4.4.4.2 Partnerships with Local Mental Health Facilities for Expansion in Non-English-Speaking Regions
8.4.4.5 Regional Analysis for Opportunities
9.1 Overview
9.2 Platforms
9.3 Devices
10.1 Overview
10.2 Stress
10.3 Anxiety
10.4 Depression
10.5 Bipolar Disorder
10.6 Schizophrenia
10.7 Others
11.1 Overview
11.2 Cognitive Behavior Therapy (CBT)
11.3 Electrotherapy
11.4 Others
12.1 Overview
12.2 Patients
12.3 Providers
12.4 Employers
12.5 Others
13.1 Overview
13.2 North America Emerging Mental Health Devices and Platforms Market
13.2.1 Key Findings
13.2.2 Market Dynamics: Impact Analysis
13.2.3 Market Size
13.2.4 North America Emerging Mental Health Devices and Platforms Market (by Product Type)
13.2.5 North America Emerging Mental Health Devices and Platforms Market (by End User)
13.2.6 North America Emerging Mental Health Devices and Platforms Market (by Country)
13.2.6.1 U.S.
13.2.6.2 Canada
13.3 Europe Emerging Mental Health Devices and Platforms Market
13.3.1 Key Findings
13.3.2 Market Dynamics: Impact Analysis
13.3.3 Market Size
13.3.4 Europe Emerging Mental Health Devices and Platforms Market (by Product Type)
13.3.5 Europe Emerging Mental Health Devices and Platforms Market (by End User)
13.3.6 Europe Emerging Mental Health Devices and Platforms Market (by Country)
13.3.6.1 Germany
13.3.6.2 U.K.
13.3.6.3 France
13.3.6.4 Italy
13.3.6.5 Spain
13.3.6.6 Rest-of-Europe
13.4 Asia-Pacific Emerging Mental Health Devices and Platforms Market
13.4.1 Key Findings
13.4.2 Market Dynamics: Impact Analysis
13.4.3 Market Size
13.4.4 Asia-Pacific Emerging Mental Health Devices and Platforms Market (by Product Type)
13.4.5 Asia-Pacific Emerging Mental Health Devices and Platforms Market (by End User)
13.4.6 Asia-Pacific Emerging Mental Health Devices and Platforms Market (by Country)
13.4.6.1 Japan
13.4.6.2 China
13.4.6.3 India
13.4.6.4 South Korea
13.4.6.5 Australia
13.4.6.6 Rest-of-Asia-Pacific
13.5 Rest-of-the-World Emerging Mental Health Devices and Platforms Market
13.5.1 Key Findings
13.5.2 Market Dynamics: Impact Analysis
13.5.3 Market Size
13.5.4 Rest-of-the-World Emerging Mental Health Devices and Platforms Market (by Product Type)
13.5.5 Rest-of-the-World Emerging Mental Health Devices and Platforms Market (by End User)
13.5.6 Rest-of-the-World Emerging Mental Health Devices and Platforms Market (by Country)
13.5.6.1 Brazil
13.5.6.2 Mexico
13.5.6.3 Rest-of-Rest-of-the-World
14.1 AbleTo, Inc.
14.1.1 Company Overview
14.1.2 Role of AbleTo, Inc. in Global Emerging Mental Health Devices and Platforms Market
14.1.3 Recent Development
14.1.4 SWOT Analysis
14.2 Calm
14.2.1 Company Overview
14.2.2 Role of Calm in Global Emerging Mental Health Devices and Platforms Market
14.2.3 Recent Development
14.2.4 SWOT Analysis
14.3 Electromedical Products International, Inc.
14.3.1 Company Overview
14.3.2 Role of Electromedical Products International, Inc. in Global Emerging Mental Health Devices and Platforms Market
14.3.3 Recent Development
14.3.4 SWOT Analysis
14.4 Flow Neuroscience AB
14.4.1 Company Overview
14.4.2 Role of Flow Neuroscience AB in Global Emerging Mental Health Devices and Platforms Market
14.4.3 Recent Development
14.4.4 SWOT Analysis
14.5 Ginger
14.5.1 Company Overview
14.5.2 Role of Ginger in Global Emerging Mental Health Devices and Platforms Market
14.5.3 Recent Development
14.5.4 SWOT Analysis
14.6 Headspace Inc.
14.6.1 Company Overview
14.6.2 Role of Headspace Inc. in Global Emerging Mental Health Devices and Platforms Market
14.6.3 Recent Development
14.6.4 SWOT Analysis
14.7 HAPPIFY HEALTH
14.7.1 Company Overview
14.7.2 Role of HAPPIFY HEALTH in Global Emerging Mental Health Devices and Platforms Market
14.7.3 Recent Development
14.7.4 SWOT Analysis
14.8 Lyra Health, Inc
14.8.1 Company Overview
14.8.2 Role of Lyra Health, Inc in Global Emerging Mental Health Devices and Platforms Market
14.8.3 Recent Development
14.8.4 SWOT Analysis
14.9 Monsenso A/S
14.9.1 Company Overview
14.9.2 Role of Monsenso A/S in Global Emerging Mental Health Devices and Platforms Market
14.9.3 Financials
14.9.4 Recent Development
14.9.5 SWOT Analysis
14.10 Neuronetics
14.10.1 Company Overview
14.10.2 Role of Neuronetics in Global Emerging Mental Health Devices and Platforms Market
14.10.3 Financials
14.10.4 Recent Development
14.10.5 SWOT Analysis
14.11 Pear Therapeutics, Inc.
14.11.1 Company Overview
14.11.2 Role of Pear Therapeutics, Inc. in Global Emerging Mental Health Devices and Platforms Market
14.11.3 Recent Development
14.11.4 SWOT Analysis
14.12 Psious
14.12.1 Company Overview
14.12.2 Role of Psious in Global Emerging Mental Health Devices and Platforms Market
14.12.3 Recent Development
14.12.4 SWOT Analysis
14.13 Quartet Health
14.13.1 Company Overview
14.13.2 Role of Quartet Health in Global Emerging Mental Health Devices and Platforms Market
14.13.3 Recent Development
14.13.4 SWOT Analysis
14.14 Talkspace
14.14.1 Company Overview
14.14.2 Role of Talkspace in Global Emerging Mental Health Devices and Platforms Market
14.14.3 Recent Development
14.14.4 SWOT Analysis
14.15 Teladoc Health, Inc.
14.15.1 Company Overview
14.15.2 Role of Teladoc Health, Inc. in Global Emerging Mental Health Devices and Platforms Market
14.15.3 Financials
14.15.4 Recent Development
14.15.5 SWOT Analysis
14.16 Woebot Health
14.16.1 Company Overview
14.16.2 Role of Woebot Health in Global Emerging Mental Health Devices and Platforms Market
14.16.3 SWOT Analysis
14.17 Ybrain, INC
14.17.1 Company Overview
14.17.2 Role of Ybrain, INC in Global Emerging Mental Health Devices and Platforms Market
14.17.3 Recent Development
14.17.4 SWOT Analysis
14.18 Company Snapshot
14.18.1 Bioself Technology Ltd
14.18.1.1 Company Overview
14.18.1.2 Role of Bioself Technology Ltd in Global Emerging Mental Health Devices and Platforms Market
14.18.1.3 Recent Development
14.18.2 INNOVATIVE NEUROLOGICAL DEVICES
14.18.2.1 Company Overview
14.18.2.2 Role of INNOVATIVE NEUROLOGICAL DEVICES in Global Emerging Mental Health Devices and Platforms Market
14.18.2.3 Recent Development
14.18.3 Lief Therapeutics
14.18.3.1 Company Overview
14.18.3.2 Role of Lief Therapeutics in Global Emerging Mental Health Devices and Platforms Market
14.18.3.3 Recent Development
14.18.4 NeuroSigma, Inc
14.18.4.1 Company Overview
14.18.4.2 Role of NeuroSigma, Inc. in Global Emerging Mental Health Devices and Platforms Market
14.18.4.3 Recent Development
14.18.5 Sentio Solutions Inc
14.18.5.1 Company Overview
14.18.5.2 Role of Sentio Solutions Inc. in Global Emerging Mental Health Devices and Platforms Market
14.18.5.3 Recent Development
Table 3.1: Secondary Data Sources
Table 4.1: Depression Levels in Medical Professionals in European Countries, 2020
Table 4.2: Mental Health Workforce Per Hundred Thousand Population, (Asia-Pacific Countries), 2017
Table 4.3: Reimbursement Codes for NeuroStar, Transcranial Magnetic Stimulation Device
Table 5.1: Global Emerging Mental Health Devices and Platforms Market, Short- Term Impact of COVID-19 on Adoption Rates
Table 5.2: Global Emerging Mental Health Devices and Platforms Market, Mid-Term Impact of COVID-19 on Adoption Rates
Table 5.3: Global Emerging Mental Health Devices and Platforms Market, Long- Term Impact of COVID-19 on Adoption Rates
Table 6.1: Global Emerging Mental Health Devices and Platforms Market, Funding Scenario
Table 6.2: Global Emerging Mental Health Devices and Platforms Market, Associations and Consortiums
Table 6.3: Telemedicine Regulatory Bodies in European Union
Table 6.4: Rest-of-the-World, Data Privacy Regulations
Table 6.5: Global Emerging Mental Health Devices and Platforms Market, Patent Filing Trend (by Country)
Table 7.1: Global Emerging Mental Health Devices and Platforms Market: Product Mapping Analysis
Table 7.2: Global Emerging Mental Health Devices and Platforms Market, Business Model Analysis
Table 7.3: Global Emerging Mental Health Devices and Platforms Market, Devices Pricing Analysis
Table 7.4: Global Emerging Mental Health Devices and Platforms Market, Mobile Platforms Pricing Analysis
Table 7.5: Global Emerging Mental Health Devices and Platforms Market, Mental Health Teleconsultation Platforms Pricing Analysis
Table 7.6: Global Emerging Mental Health Devices and Platforms Market, Product Pipeline
Table 8.1: Privacy Policy of Mental Health Platforms, Comparison Analysis
Table 8.2: Global Emerging Mental Health Devices and Platforms Market, Regional Opportunity Analysis
Table 9.1: Global Emerging Mental Health Devices and Platforms Market, Key Platform Players
Table 9.2: Global Emerging Mental Health Devices and Platforms Market, Key Devices Players
Table 10.1: Impact of Stress on Human Health
Table 13.1: North America Emerging Mental Health Devices and Platforms Market, Impact Analysis
Table 13.2: Europe Emerging Mental Health Devices and Platforms Market, Impact Analysis
Table 13.3: Asia-Pacific Countries: Mental Health Workforce Per 100,000 Population, 2017
Table 13.4: Asia-Pacific Emerging Mental Health Devices and Platforms Market, Impact Analysis
Table 13.5: Rest-of-the-World Emerging Mental Health Devices and Platforms Market, Impact Analysis
Table 14.1: AbleTo, Inc.: Key Product Features
Table 14.2: Monsenso A/S: mHealth Solution Key Components
Table 14.3: Pear Therapeutics, Inc.: Products Key Features
Table 14.4: Pear Therapeutics, Inc.: Product Pipeline for Global Emerging Mental Health Devices and Platforms Market
Table 14.5: Woebot Health: Product Pipeline for Global Emerging Mental Health Devices and Platforms Market
Figure 1: Global Prevalence of Mental Disorders (by Region), 2010-2019
Figure 2: Global Emerging Mental Health Devices and Platforms Market, $Million, 2019-2030
Figure 3: Global Emerging Mental Health Devices and Platforms Market, COVID-19 Impact
Figure 4: Global Emerging Mental Health Devices and Platforms Market: Drivers and Restraints Impact Analysis
Figure 5: Global Emerging Mental Health Devices and Platforms Market (by Company), 2019
Figure 6: Global Emerging Mental Health Devices and Platforms Market, Share of Key Developments and Strategies, January 2017-February 2021
Figure 7: Global Emerging Mental Health Devices and Platforms Market (by Application), 2019 Vs. 2030
Figure 8: Global Emerging Mental Health Devices and Platforms Market (by Therapy), 2019 Vs. 2030
Figure 9: Global Emerging Mental Health Devices and Platforms Market (by Region), 2019 and 2030
Figure 2.1: Global Emerging Mental Health Devices and Platforms Market Segmentation
Figure 2.2: Global Emerging Mental Health Devices and Platforms Market, Regional Segmentation
Figure 3.1: Global Emerging Mental Health Devices and Platforms Market: Research Methodology
Figure 3.2: Primary Research
Figure 3.3: Secondary Research
Figure 3.4: Total Number of Healthcare Company Profiles
Figure 3.5: Assumptions and Limitations
Figure 4.1: Prevalence of Mental Health Disorders in North America, 2010-2019
Figure 4.2: Prevalence of Mental Health Disorders in Europe, 2010-2019
Figure 4.3: Prevalence of Mental Health Disorders in Asia-Pacific, 2010-2019
Figure 4.4: Prevalence of Mental Health Disorders in Rest-of-the-World, 2010-2019
Figure 4.5: Psychiatrist Density in North America, 2000-2018
Figure 4.6: Psychiatrist Density in Europe, 2000-2018
Figure 4.7: Psychiatrist Density in Asia-Pacific, 2000-2018
Figure 4.8: Reimbursement Channel for Mental Health Mobile Application in the U.S.
Figure 5.1: Global Emerging Mental Health Devices and Platforms Market: Impact of COVID-19 on Regulatory Framework
Figure 5.2: Global Emerging Mental Health Devices and Platforms Market: Scenario Comparison Analysis
Figure 5.3: Global Emerging Mental Health Devices and Platforms Market: Key Developments During COVID-19 Pandemic, 2020
Figure 5.4: Global Emerging Mental Health Devices and Platforms Market: Entry Barriers and Opportunities for New Entrants
Figure 6.1: Global Emerging Mental Health Devices and Platforms Market: Key Technology Trends
Figure 6.2: Global Emerging Mental Health Devices and Platforms Market, Short-Term Potential of Key Trends
Figure 6.3: Global Emerging Mental Health Devices and Platforms Market, Mid-Term Potential of Key Trends
Figure 6.4: Global Emerging Mental Health Devices and Platforms Market, Long-Term Potential of Key Trends
Figure 6.5: Global Emerging Mental Health Devices and Platforms Market, Value Chain Analysis
Figure 6.6: Global Emerging Mental Health Devices and Platforms Market, Patent Filing Trend (by Year)
Figure 7.1: Global Emerging Mental Health Devices and Platforms Market, (by Company), 2019
Figure 7.2: Global Emerging Mental Health Platforms Market, (by Company), 2019
Figure 7.3: Global Emerging Mental Health Devices and Platforms Market, Share of Key Developments and Strategies, 2017-February 2021
Figure 7.4: Global Emerging Mental Health Devices and Platforms Market, Partnerships, Collaborations, and Business Expansion (by Company), 2017- February 2021
Figure 7.5: Global Emerging Mental Health Devices and Platforms Market, Funding Activities (by Company), 2017- February 2021
Figure 7.6: Global Emerging Mental Health Devices and Platforms Market, New Offerings (by Company), 2017- February 2021
Figure 7.7: Global Emerging Mental Health Devices and Platforms Market, Regulatory and Legal (by Company), 2017- February 2021
Figure 7.8: Global Emerging Mental Health Devices and Platforms Market, M&A Activities (by Company), 2017- February 2021
Figure 7.9: Global Emerging Mental Health Devices and Platforms Market, Growth Share Matrix (by Product Type), 2019-2030
Figure 7.10: Global Emerging Mental Health Devices and Platforms Market, Growth Share Matrix (by Application), 2019-2030
Figure 8.1 Global Emerging Mental Health Devices and Platforms Market, Realistic Scenario, $Million,2019-2030
Figure 8.2: Global Emerging Mental Health Devices and Platforms Market, Pessimistic/ Conservative Growth Scenario, 2019-2030
Figure 8.3: Global Emerging Mental Health Devices and Platforms Market, Optimistic Scenario, $Million,2019-2030
Figure 8.4: Adults Reporting Symptoms of Anxiety and Depression, January-June 2019 Vs. January 2021
Figure 8.5: Increasing Funding Activity, 2017-2020
Figure 8.6: Global Emerging Mental Health Devices and Platforms Market: Drivers and Restraints Impact Analysis
Figure 9.1: Global Emerging Mental Health Devices and Platforms Market (by Product Type), $Million, 2019 and 2030
Figure 9.2: Global Emerging Mental Health Devices and Platforms Market (Platforms), $Million, 2019-2030
Figure 9.3: Global Emerging Mental Health Devices and Platforms Market (Devices), $Million, 2019-2030
Figure 10.1: Global Emerging Mental Health Devices and Platforms Market (by Application), $Million, 2019 and 2030
Figure 10.2: Global Emerging Mental Health Devices and Platforms Market (Stress), $Million, 2019-2030
Figure 10.3: Global Emerging Mental Health Devices and Platforms Market (Anxiety), $Million, 2019-2030
Figure 10.4: Global Emerging Mental Health Devices and Platforms Market (Depression), $Million, 2019-2030
Figure 10.5: Global Emerging Mental Health Devices and Platforms Market (Bipolar Disorder), $Million, 2019-2030
Figure 10.6: Global Emerging Mental Health Devices and Platforms Market (Schizophrenia), $Million, 2019-2030
Figure 10.7: Global Emerging Mental Health Devices and Platforms Market (Others), $Million, 2019-2030
Figure 11.1: Global Emerging Mental Health Devices and Platforms Market (by Therapy), $Million, 2019 and 2030
Figure 11.2: Global Emerging Mental Health Devices and Platforms Market (Cognitive Behavior Therapy), $Million, 2019-2030
Figure 11.3: Global Emerging Mental Health Devices and Platforms Market (Electrotherapy), $Million, 2019-2030
Figure 11.4: Global Emerging Mental Health Devices and Platforms Market (Others), $Million, 2019-2030
Figure 12.1: Global Emerging Mental Health Devices and Platforms Market (by End User), $Million, 2019 and 2030
Figure 12.2: Global Emerging Mental Health Devices and Platforms Market (Patients), $Million, 2019-2030
Figure 12.3: Global Emerging Mental Health Devices and Platforms Market (Providers), $Million, 2019-2030
Figure 12.4 Global Emerging Mental Health Devices and Platforms Market (Employers), $Million, 2019-2030
Figure 12.5: Global Emerging Mental Health Devices and Platforms Market (Others), $Million, 2019-2030
Figure 13.1: Global Emerging Mental Health Devices and Platforms Market (by Region), 2019 and 2030
Figure 13.2: Global Emerging Mental Health Devices and Platforms Market (by Region), $Million, 2019-2030
Figure 13.3: North America Emerging Mental Health Devices and Platforms Market, $Million, 2019-2030
Figure 13.4: North America Emerging Mental Health Devices and Platforms Market (by Product Type), $Million, 2019-2030
Figure 13.5: North America Emerging Mental Health Devices and Platforms Market (by End User), $Million, 2019-2030
Figure 13.6: North America Emerging Mental Health Devices and Platforms Market (by Country), 2019 and 2030
Figure 13.7: Number of Psychiatrists in the U.S., Growth Trend, 2000-2018
Figure 13.8: U.S. Emerging Mental Health Devices and Platforms Market, $Million, 2019-2030
Figure 13.9: Number of Psychiatrists in Canada, Growth Trend, 2000-2018
Figure 13.10: Canada Emerging Mental Health Devices and Platforms Market, $Million, 2019-2030
Figure 13.11: Europe Emerging Mental Health Devices and Platforms Market, $Million, 2019-2030
Figure 13.12: Europe Emerging Mental Health Devices and Platforms Market (by Product Type), $Million, 2019-2030
Figure 13.13: Europe Emerging Mental Health Devices and Platforms Market (by End User), $Million, 2019-2030
Figure 13.14: Europe Emerging Mental Health Devices and Platforms Market (by Country), 2019 and 2030
Figure 13.15: Number of Psychiatrists in Germany, Growth Trend, 2000-2018
Figure 13.16: Germany Emerging Mental Health Devices and Platforms Market, $Million, 2019-2030
Figure 13.17: Number of Psychiatrists in the U.K., Growth Trend, 2000-2018
Figure 13.18: U.K. Emerging Mental Health Devices and Platforms Market, $Million, 2019-2030
Figure 13.19: Number of Psychiatrists in France, Growth Trend, 2000-2018
Figure 13.20: France Emerging Mental Health Devices and Platforms Market, $Million, 2019-2030
Figure 13.21: Number of Psychiatrists in Italy, Growth Trend, 2000-2018
Figure 13.22: Italy Emerging Mental Health Devices and Platforms Market, $Million, 2019-2030
Figure 13.23: Number of Psychiatrists in Spain, Growth Trend, 2000-2018
Figure 13.24: Spain Emerging Mental Health Devices and Platforms Market, $Million, 2019-2030
Figure 13.25: Rest-of-Europe Emerging Mental Health Devices and Platforms Market, $Million, 2019-2030
Figure 13.26: Asia-Pacific Emerging Mental Health Devices and Platforms Market, $Million, 2019-2030
Figure 13.27: Asia-Pacific Emerging Mental Health Devices and Platforms Market (by Product Type), $Million, 2019-2030
Figure 13.28: Asia-Pacific Emerging Mental Health Devices and Platforms Market (by End User), $Million, 2019-2030
Figure 13.29: Asia-Pacific Emerging Mental Health Devices and Platforms Market (by Country), 2019 and 2030
Figure 13.30: Number of Psychiatrists in Japan, Growth Trend, 2000-2018
Figure 13.31: Japan Emerging Mental Health Devices and Platforms Market, $Million, 2019-2030
Figure 13.32: Number of Psychiatrists in China, Growth Trend, 2000-2018
Figure 13.33: China Emerging Mental Health Devices and Platforms Market, $Million, 2019-2030
Figure 13.34: Number of Psychiatrists in India, Growth Trend, 2000-2018
Figure 13.35: India Emerging Mental Health Devices and Platforms Market, $Million, 2019-2030
Figure 13.36: Number of Psychiatrists in South Korea, Growth Trend, 2000-2018
Figure 13.37: South Korea Emerging Mental Health Devices and Platforms Market, $Million, 2019-2030
Figure 13.38: Number of Psychiatrists in Australia, Growth Trend, 2000-2018
Figure 13.39: Australia Emerging Mental Health Devices and Platforms Market, $Million, 2019-2030
Figure 13.40: Rest-of-Asia-Pacific Emerging Mental Health Devices and Platforms Market, $Million, 2019-2030
Figure 13.41: Rest-of-the-World Emerging Mental Health Devices and Platforms Market, $Million, 2019-2030
Figure 13.42: Rest-of-the-World Emerging Mental Health Devices and Platforms Market (by Product Type), $Million, 2019-2030
Figure 13.43: Rest-of-the-World Emerging Mental Health Devices and Platforms Market (by End User), $Million, 2019-2030
Figure 13.44: Rest-of-the-World Emerging Mental Health Devices and Platforms Market (by Country), 2019 and 2030
Figure 13.45: Number of Psychiatrists in Brazil, Growth Trend, 2000-2018
Figure 13.46: Brazil Emerging Mental Health Devices and Platforms Market, $Million, 2019-2030
Figure 13.47: Number of Psychiatrists in Mexico, Growth Trend, 2000-2018
Figure 13.48: Mexico Emerging Mental Health Devices and Platforms Market, $Million, 2019-2030
Figure 13.49: Rest-of-Rest-of-the-World Emerging Mental Health Devices and Platforms Market, $Million, 2019-2030
Figure 14.1: AbleTo, Inc.: Overall Product Portfolio
Figure 14.2: AbleTo, Inc.: SWOT Analysis
Figure 14.3: Calm: Overall Product Portfolio
Figure 14.4: Calm: SWOT Analysis
Figure 14.5: Electromedical Products International, Inc.: Overall Product Portfolio
Figure 14.6: Electromedical Products International, Inc.: SWOT Analysis
Figure 14.7: Flow Neuroscience AB: Overall Product Portfolio
Figure 14.8: Flow Neuroscience AB: SWOT Analysis
Figure 14.9: Ginger: Overall Product Portfolio
Figure 14.10: Ginger: SWOT Analysis
Figure 14.11: Headspace Inc.: Overall Product Portfolio
Figure 14.12: Headspace Inc.: SWOT Analysis
Figure 14.13: HAPPIFY HEALTH: Overall Product Portfolio
Figure 14.14: HAPPIFY HEALTH: SWOT Analysis
Figure 14.15: Lyra Health, Inc: Overall Product Portfolio
Figure 14.16: Lyra Health, Inc.: SWOT Analysis
Figure 14.17: Monsenso A/S: Overall Product Portfolio
Figure 14.18: Monsenso A/S: Overall Revenue, 2017-2019
Figure 14.19: Monsenso A/S: SWOT Analysis
Figure 14.20: Neuronetics: Overall Product Portfolio
Figure 14.21: Neuronetics: Overall Revenue, 2017-2019
Figure 14.22: Neuronetics: Revenue (by Business Segment), 2017-2019
Figure 14.23: Neuronetics: Revenue (by Region), 2017-2019
Figure 14.24: Neuronetics: SWOT Analysis
Figure 14.25: Pear Therapeutics, Inc.: SWOT Analysis
Figure 14.26: Psious: Overall Product Portfolio
Figure 14.27: Psious: SWOT Analysis
Figure 14.28: Quartet Health: Overall Product Portfolio
Figure 14.29: Quartet Health: SWOT Analysis
Figure 14.30: Talkspace: Overall Product Portfolio
Figure 14.31: Talkspace: SWOT Analysis
Figure 14.32: Teladoc Health, Inc.: Overall Product Portfolio
Figure 14.33: Teladoc Health, Inc.: Overall Revenue, 2017-2019
Figure 14.34: Teladoc Health, Inc.: SWOT Analysis
Figure 14.35: Woebot Health: Overall Product Portfolio
Figure 14.36: Woebot Health: SWOT Analysis
Figure 14.37: Ybrain, INC: Overall Product Portfolio
Figure 14.38: Ybrain,INC: SWOT Analysis
Report Description
Market Report Coverage - Emerging Mental Health Devices and Platforms |
|||
Base Year |
2019 |
Market Size in 2019 |
$1,362.4 Million |
Forecast Period |
2021-2030 |
Value Projection and Estimation by 2030 |
$18,717.5 Million |
CAGR During Forecast Period |
24.69% |
Number of Tables |
33 |
Number of Pages |
269 |
Number of Figures |
156 |
Research Hours |
700 |
|
|
Market Segmentation |
• Product Type (Platforms and Devices) • Application (Stress, Anxiety, Depression, Bipolar Disorder, Schizophrenia, and Others) • Therapy (Cognitive Behavior Therapy, Electrotherapy, and Others) • End Users (Patients, Providers, Employers, and Others) |
||
Regional Segmentation |
• North America • Europe • Asia-Pacific • Rest-of-the-World |
||
Growth Drivers |
• Growing Demand for Teleconsultations in the Wake of COVID-19 Pandemic • Increasing Funding Activity in Digital Mental Health Landscape • Rising Adoption of Digital Mental Health Solutions in Emerging Economies • Entry of Pharmaceutical Companies in Digital Mental Health Paradigm |
||
Market Challenges |
• Lack of Clinically Validated Scientific Data • User Data Privacy Concerns |
||
Market Opportunities |
• Development of Portable Mental Health Devices • Development of Novel Therapies for Mental Health Treatment • Product Portfolio Expansion • Business Collaborations |
||
Key Companies Profiled |
AbleTo, Inc., Calm, Electromedical Products International, Inc., Flow Neuroscience AB, Ginger, HAPPIFY HEALTH, Headspace Inc., Lyra Health, Inc., Monsenso A/S, Neuronetics, Pear Therapeutics, Inc., Psious, Quartet Health, Talkspace, Teladoc Health, Inc., Woebot Health, and Ybrain, INC. |
Key Questions Answered in this Report:
• How do attributes such as the prevalence of mental illnesses, physician density, and payment scenario impact the global emerging mental health devices and platforms market?
• What impact did the COVID-19 pandemic have on the adoption of mental health mobile applications?
• What were the key developments in the global emerging mental health devices and platforms market during the COVID-19 pandemic?
• What impact do the emerging mental health devices and platforms have on the industry ecosystem?
• What are the key technologies that received significant funding in 2020?
• Which key synergistic activity was majorly utilized by the companies in the global emerging mental health devices and platforms market?
• What are the pipeline products that are anticipated to be commercialized during the forecast period 2021-2030?
• What are the key business models employed by the companies operating in the market?
• What are the key driving and inhibiting factors in the global emerging mental health devices and platforms market? What will be their impact on the market during the forecast period 2021-2030?
• Which mental health application is anticipated to witness significant growth during the forecast period 2021-2030?
• Which mental health therapy held the largest share in the global emerging mental health devices and platforms market in 2020?
• Which region holds the highest growth potential in the global emerging mental health devices and platforms market during the forecast period 2021-2030?
• Who are the end users of the novel mental health solutions? Which end-user category holds the significant growth potential during the forecast period 2021-2030?
Market Overview
Global Emerging Mental Health Devices and Platforms Market Forecast (2021-2030)
Key USPs of the Report
Following are some of the key contents of the report:
• Funding Scenario
This section encompasses a description of the current funding landscape in the global emerging mental health devices and platforms market for key players.
• Key Technology Trends
This section identifies key technology trends that would influence the market and their short-term, mid-term, and long-term growth potential.
• Pipeline Analysis
This section comprises information on the pipeline products that would impact the growth trajectory of the global emerging mental health devices and platforms market
• Impact of COVID-19
This section of the report encompasses the following:
o Impact on government initiatives and regulations
o Future impact (Short-, mid-, and long-term)
o Key developments during the COVID-19 pandemic
o Scenario comparison analysis
Also, the report provides:
• A detailed analysis and growth forecast (2021-2030) for different market segments
• Recent developments and trends in the global market landscape
• Factors promoting and inhibiting the market growth
Scope of the Global Emerging Mental Health Devices and Platforms Market
The purpose of the study is to enable the reader to gain a holistic view of the global emerging mental health devices and platforms market, by each of the segments mentioned above.
The report constitutes an in-depth analysis of the global emerging mental health devices and platforms market, including a thorough analysis of the applications. The study also provides market and business-related information on various products, applications, therapies, and end users. The report considers emerging mental health devices and mobile health platforms.
Key Companies in the Global Emerging Mental Health Devices and Platforms Market
Some of the key players contributing to the global emerging mental health devices and platforms market include AbleTo, Inc., Calm, Electromedical Products International, Inc., Flow Neuroscience AB, Ginger, HAPPIFY HEALTH, Headspace Inc., Lyra Health, Inc., Monsenso A/S, Neuronetics, Pear Therapeutics, Inc., Psious, Quartet Health, Talkspace, Teladoc Health, Inc., Woebot Health, and Ybrain, INC.
Global Emerging Mental Health Devices and Platforms Market
Analysis and Forecast, 2021-2030
Frequently Asked Questions
The emerging mental health devices and platforms market was estimated at $1,362.4 Million in 2019 and is expected to grow at a CAGR of 24.69% during the forecast period from 2021 to 2030.
Possible opportunities that can boost the growth of the market include development of portable mental health devices and development of novel therapies for mental health treatment.
Factors driving the growth of the market include growing demand for teleconsultations in the wake of covid-19 pandemic, increasing funding activity in digital mental health landscape, rising adoption of digital mental health solutions in emerging economies, and entry of pharmaceutical companies in digital mental health paradigm.
Applications for which mental health devices and platforms can be used include stress, anxiety, depression, bipolar disorder, schizophrenia, and others.
Key players operating in the market include AbleTo, Inc., Calm, Electromedical Products International, Inc., Flow Neuroscience AB, Ginger, HAPPIFY HEALTH, Headspace Inc., Lyra Health, Inc., Monsenso A/S, Neuronetics, Pear Therapeutics, Inc., Psious, Quartet Health, Talkspace, Teladoc Health, Inc., Woebot Health, and Ybrain, INC., among others.